National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

talampanel
A synthetic derivative of dioxolo-benzodiazepine with anti-seizure activity. Talampanel noncompetitively binds to the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) subtype of glutamate excitatory amino acid receptors and may inhibit the growth of gliomas by interfering with neurotransmitters involved in brain tumor growth. This agent may also protect against traumatic brain injury. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:LY 300164
Code name:GYKI-53773



Previous:tacrolimus, tadalafil, Tagamet, talabostat mesylate, talactoferrin
Next:talaporfin sodium, talc, talotrexin ammonium, Talvesta, tamibarotene

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov